4//SEC Filing
Prentiss Christopher B 4
Accession 0001209191-21-016939
CIK 0001328143other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:56 PM ET
Size
5.2 KB
Accession
0001209191-21-016939
Insider Transaction Report
Form 4
Prentiss Christopher B
Chief Accounting Officer
Transactions
- Award
Common Stock
2021-03-02+75,000→ 147,439 total
Footnotes (1)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 1/3rd of the total number of Restricted Stock Units will vest on each of March 1, 2022, March 1, 2023 and March 1, 2024, subject to Reporting Person's Continuous Service as of each such date.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001717583
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:56 PM ET
- Size
- 5.2 KB